Medicare Enrolled
Dr. Linda Osborne, D.O.
Urology Physician · Gahanna, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Osborne from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Osborne?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Osborne
Dr. Linda Osborne is an urology physician in Gahanna, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Osborne performed 3,596 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Osborne received a total of $3,486 from 43 pharmaceutical and/or device companies across 135 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Osborne is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 13% volume in OH
$3,486 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,596
Medicare services
Top 13% in OH for urology physician
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,200 | $0 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
428 | $56 | $180 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
222 | $46 | $182 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
83 | $7 | $153 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
70 | $3 | $7 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
61 | $8 | $31 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
59 | $2 | $12 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
57 | $38 | $113 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
50 | $18 | $75 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
46 | $92 | $464 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
44 | $71 | $251 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
42 | $36 | $139 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
39 | $125 | $755 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $90 | $339 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $100 | $324 |
| PSA test (prostate cancer screening) | 26 | $18 | $71 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
22 | $4 | $14 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
19 | $170 | $1,031 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
15 | $19 | $61 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $91 | $383 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
13 | $3 | $144 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
12 | $59 | $578 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
11 | $1 | $3 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.1% high complexity
65.1% medium
33.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,486
Total received (2018-2024)
Avg $498/year across 7 years
Top 38% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
135
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$790
2023
$529
2022
$455
2021
$327
2020
$147
2019
$675
2018
$563
Payments by company (2024)
PROGENICS PHARMACEUTICALS, INC.
$185
Merck Sharp & Dohme LLC
$126
PFIZER INC.
$90
BLUEWIND MEDICAL
$89
ABBVIE INC.
$59
Endo Pharmaceuticals Inc.
$39
Tolmar, Inc.
$38
UROGEN PHARMA, INC.
$36
Sumitomo Pharma America, Inc.
$35
Endo USA, Inc.
$28
Astellas Pharma US Inc
$21
Janssen Biotech, Inc.
$18
Teleflex LLC
$15
Calyxo, Inc.
$14
Top 3 companies account for 50.7% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$568
NeoTract Inc.
$188
PROGENICS PHARMACEUTICALS, INC.
$185
Axonics, Inc.
$179
Allergan Inc.
$175
Janssen Biotech, Inc.
$159
Boston Scientific Corporation
$153
Olympus America Inc.
$150
Endo Pharmaceuticals Inc.
$140
UROVANT SCIENCES INC
$134
Merck Sharp & Dohme LLC
$126
PFIZER INC.
$119
Sumitomo Pharma America, Inc.
$109
Medtronic, Inc.
$93
BLUEWIND MEDICAL
$89
Rochester Medical Corporation
$89
Kowa Pharmaceuticals America, Inc.
$73
Medtronic USA, Inc.
$68
UroGen Pharma, Inc.
$68
Myovant Sciences Inc.
$61
ABBVIE INC.
$59
Antares Pharma, Inc.
$52
Laborie Medical Technologies Corp.
$41
Bayer HealthCare Pharmaceuticals Inc.
$39
Tolmar, Inc.
$38
UROGEN PHARMA, INC.
$36
TOLMAR Pharmaceuticals, Inc.
$31
Endo USA, Inc.
$28
BOSTON SCIENTIFIC CORPORATION
$22
Blue Earth Diagnostics Limited
$21
180 Medical, Inc.
$18
C. R. Bard, Inc. & Subsidiaries
$18
Alexion Pharmaceuticals, Inc.
$18
Photocure Inc
$16
PROCEPT BioRobotics Corporation
$15
MEDIVATION FIELD SOLUTIONS LLC
$15
Teleflex LLC
$15
Allergan, Inc.
$15
AbbVie Inc.
$14
Calyxo, Inc.
$14
E.R. Squibb & Sons, L.L.C.
$13
Coloplast Corp
$13
Avadel Specialty Pharmaceuticals, LLC
$12
Top 3 companies account for 27.0% of all-time payments
Associated products mentioned in payments ›
ALTIS · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AVEED · Axonics · Axumin · BOTOX · CVAC ASPIRATION SYSTEM · Cysview · ELIGARD · ERLEADA · Erleada · GEMTESA · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · MYRBETRIQ · Myrbetriq · Noctiva · Nubeqa · OPDIVO · ORGOVYX · Otrexup · PYLARIFY · REVI · REZUM · SEGLENTIS · UROLIFT · Ultomiris · UroLift · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
99
County median income
$73,795
Nearest hospital to ZIP centroid (approximate)
MOUNT CARMEL NEW ALBANY SURGICAL HOSPITAL
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Osborne is a clinical cardiology specialist, with above-average Medicare volume (top 13% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Osborne experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Osborne performed 2,200 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Osborne receive payments from pharmaceutical companies?
Yes. Dr. Osborne received a total of $3,486 from 43 companies across 135 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Osborne's costs compare to other urology physicians in Gahanna?
Dr. Osborne's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Osborne) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Gahanna
Browse urology physicians in Gahanna ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
PROGENICS PHARMACEUTICALS, INC. Payments to Doctors
See all physicians who received payments from PROGENICS PHARMACEUTICALS, INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology